Can a memory loss drug already on the market prevent Alzheimer’s disease? Study in the works

  • 📰 cleveland19news
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 68%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

Case Western Reserve University and University Hospitals is using an existing drug, FDA approved for memory loss, to see if it can prevent the disease from forming.

CLEVELAND, Ohio - Could a drug already on the market help prevent Alzheimer’s disease decades before it even shows up in patients prone to the disease? for memory loss, and giving it to people at risk for Alzheimer’s and Dementia, long before symptoms begin.

“What we know is that Alzheimer’s disease actually starts in the brain almost 20 years prior to any symptoms,” Dr. Alan Lerner told 19 News. “So if your mom developed symptoms at 80 there changes in the brain have been there possibly since you was 60.” Patients participating don’t have memory loss, yet, but they do have amyloid protein deposits in the brain, a hallmark of Alzheimer’s disease.

“The nice part about it is you’re monitored all the time as far as blood tests, brain scans, MRI’s,” said Kerr.But he has full faith that they’re moving in the right direction.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 70. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها